APA citiranje

Choudhary, G. S., Al-harbi, S., Mazumder, S., Hill, B. T., Smith, M. R., Bodo, J., . . . Almasan, A. (2015). MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies. Cell Death Dis.

Citação norma Chicago

Choudhary, G S., S. Al-harbi, S. Mazumder, B T. Hill, M R. Smith, J. Bodo, E D. Hsi, and A. Almasan. "MCL-1 and BCL-xL-dependent Resistance to the BCL-2 Inhibitor ABT-199 Can Be Overcome By Preventing PI3K/AKT/mTOR Activation in Lymphoid Malignancies." Cell Death Dis 2015.

MLA citiranje

Choudhary, G S., et al. "MCL-1 and BCL-xL-dependent Resistance to the BCL-2 Inhibitor ABT-199 Can Be Overcome By Preventing PI3K/AKT/mTOR Activation in Lymphoid Malignancies." Cell Death Dis 2015.